Eurazeo, MxEP, Ardian and Eximium enter into exclusive discussions with SK Capital to sell their stake in Seqens

Published on
1 month 3 weeks ago

Five years after their entry into the capital of Seqens, Eurazeo (majority shareholder), Merieux Equity Partners through its vehicle Mérieux Participations 2 (“MP2”), Ardian and Eximium today announced that they have entered into exclusive discussions to sell their stake in Seqens to funds advised by SK Capital Partners. The deal is expected to close by the end of 2021.